25,745.15
(436.25)
(1.72%)
03 Jul , 2026 | 04:14 PM
Open
25,402.6
Prev. Close
25,308.9
Market Cap.
₹19,78,078.71
Div Yield
0.62
PE
38.67
PB
38.67
25,399.9
25,861.5
Performance
One Week (%)
1.35
One Month (%)
5.42
One Year (%)
14.46
YTD (%)
14.97
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 25,895 | 26,120 | 25,615 | 21,108 |
Cipla Ltd | 1,458.2 | 1,471 | 1,452 | 12,61,674 |
J B Chemicals & Pharmaceuticals Ltd | 2,364.6 | 2,371.8 | 2,327.9 | 1,08,305 |
Dr Reddys Laboratories Ltd | 1,374.1 | 1,390.4 | 1,350.3 | 12,96,170 |
Lupin Ltd | 2,476 | 2,481 | 2,407.6 | 9,39,595 |
Torrent Pharmaceuticals Ltd | 4,768.3 | 4,783 | 4,680 | 3,45,920 |
Ipca Laboratories Ltd | 1,778.9 | 1,788.3 | 1,719.4 | 5,71,448 |
Sun Pharmaceutical Industries Ltd | 1,904.8 | 1,925.1 | 1,871.6 | 21,68,491 |
Aurobindo Pharma Ltd | 1,620.5 | 1,636.8 | 1,567.7 | 21,90,579 |
Wockhardt Ltd | 1,938.5 | 1,982.8 | 1,928 | 6,40,010 |
Ajanta Pharma Ltd | 3,326.3 | 3,420 | 3,309.1 | 83,885 |
Gland Pharma Ltd | 2,462.3 | 2,524.6 | 2,445.2 | 5,25,087 |
Biocon Ltd | 426.8 | 428.8 | 418.6 | 64,03,875 |
Alkem Laboratories Ltd | 5,562.5 | 5,631 | 5,494 | 5,68,290 |
Glenmark Pharmaceuticals Ltd | 2,211 | 2,244.5 | 2,185.2 | 6,32,010 |
Zydus Lifesciences Ltd | 1,140.6 | 1,142.9 | 1,104.1 | 18,62,016 |
Divis Laboratories Ltd | 6,757 | 6,804.5 | 6,685.5 | 3,82,822 |
Mankind Pharma Ltd | 2,528.6 | 2,543 | 2,480.2 | 3,92,427 |
Laurus Labs Ltd | 1,542.3 | 1,555 | 1,522 | 33,34,092 |
Piramal Pharma Ltd | 175.95 | 179.25 | 168.1 | 3,34,16,572 |
The Indian stock market extended its gains on July 2, 2026, with the Nifty closing at 24,175.70 and the Sensex rising 579 points. A strong rebound in IT stocks, lower Brent crude prices, easing US-Iran tensions, a stronger rupee, and lower India VIX boosted investor confidence, while Realty, Auto, Chemicals, Cement, and Consumer Durables also ended in positive territory.
2 Jul 2026|07:30 PM
Indian benchmark indices snapped a two-session losing streak on July 1, 2026, as the Nifty 50 climbed above the 24,000 mark and the Sensex gained 444 points. The rally was driven by easing crude oil prices, positive global cues, strong June auto sales, and broad-based buying in Realty, FMCG, Auto, and financial stocks, while IT remained under pressure amid concerns over slowing global technology spending.
1 Jul 2026|06:43 PM
The Indian stock market ended in the red on June 29, 2026, as renewed US-Iran tensions, higher crude oil prices, and profit booking weighed on investor sentiment. Nifty slipped to 23,946 while Sensex lost 372 points. Pharma stocks emerged as the top performers on biosimilar and export optimism, whereas Auto, IT, and Cement sectors witnessed broad-based selling amid cautious global cues.
29 Jun 2026|05:16 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
